Arrhythmia Monitoring Devices Market Is Poised To Uplift Around $8.41 Billion By 2025

San Francisco, 02 Apr 2019 - “Arrhythmia Monitoring Devices Market Size, Share & Trends Analysis Report By Type (ECG, Implantable, Holter, Mobile Cardiac Telemetry), By Application, By End Use, And Segment Forecasts, 2018 - 2025” - The global arrhythmia monitoring devices market size is expected to reach USD 8.41 billion in 2025 with a CAGR of 6.8% during the forecast period, according to a new report by Grand View Research, Inc. Continuous R&D activities in the field of cardiac monitoring are leading to technological expansion. This, in turn, is positively influencing the growth of the arrhythmia monitoring devices market. Wearable diagnostic patch by iRhythm Technologies, Inc., Zio, has led to symptomatic arrhythmia monitoring, which is superior in comparison to conventional Holter monitors.

“Biotronik Home Monitoring which aims to decrease hospitalizations and impermanence due to heart Failure. Biotronik has acknowledged FDA approvals for two families of high-voltage cardiac rhythm management devices.”

Big pharma and medical device companies are heavily investing in R&D to perform a detailed mapping of cardiac arrhythmia. In February 2018, Medtronic received FDA clearance for the first non-invasive cardiac mapping system, CardioInsight. It includes wearable 252-electrode sensor vest that creates 3D electroanatomic maps of heart by combining data from a cardiac computed tomography scan with ECG signals collected from the chest region.

In addition to these technologies, emergence and advancements in mobile cardiac telemetry are leading to further progress of the overall market. In October 2017, Abbott received FDA clearance for Confirm Rx, a smartphone-compatible implantable cardiac monitor indicated for arrhythmia diagnosis. Boston Scientific announced its FDA approval for Resonate, a line of cardiac resynchronization therapy defibrillator and cardioverter defibrillator systems for the cardiac management.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/arrhythmia-monitoring-devices-market 

Further key findings from the report suggest:

• The arrhythmia monitoring devices market is highly competitive and is rapidly evolving with numerous potential market players
• Holter monitors dominated the market in terms of revenue in 2017. On the other hand, mobile cardiac telemetry is expected to witness the fastest growth rate during the forecast period
• Atrial fibrillation dominated the market in terms of revenue in 2017. The growth in the number of untreated cases of arrhythmias are leading to increasing need for advanced cardiac monitoring devices
• Heightened adoption of sophisticated technologies has led to the expansion of the market. Kardia Mobile by AliveCor captures ECG in 30 seconds projecting the heart rhythm for conditions such as atrial fibrillation
• The hospitals and clinics segment held the largest share in the market in 2017. On the other hand, diagnostic centers are likely to experience the fastest growth over the forecast period
• North America commanded the leading share in the market in 2017 due to faster regulatory approvals for innovative devices and procedures
• AliveCor, Inc.; Applied Cardiac Systems; BioTelemetry, Inc.; BIOTRONIK; Fukuda Denshi Co., Ltd.; GE Healthcare; iRhythm; Medi-Lynx; St. Jude Medical (Abbott); Medtronic; Nihon Kohden Corporation; Nuubo; and Spacelabs Healthcare are some of the key players operating in this market.

Access More Reports Of The Same Category: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global arrhythmia monitoring devices market based on type, application, end use, and region:

Arrhythmia Monitoring Devices Type Outlook (Revenue, USD Million, 2014 - 2025)

• ECG Monitors
• Implantable Monitors
• Holter Monitors
• Mobile Cardiac Telemetry

Arrhythmia Monitoring Devices Application Outlook (Revenue, USD Million, 2014 - 2025)

• Bradycardia
• Tachycardia
• Atrial Fibrillation
• Ventricular Fibrillation
• Premature Contraction
• Others

Arrhythmia Monitoring Devices End Use Outlook (Revenue, USD Million, 2014 - 2025)

• Hospitals & Clinics
• Diagnostic Centers
• Others

Arrhythmia Monitoring Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-arrhythmia-monitoring-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com